gip/glp-1 receptor agonist mechanism of action Possible mechanisms of glucagon-like peptide-1 agonists on blood pressure beyond body weight Cardiovascular effects of Glucagon-like peptide

Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants

and Nataraj

Blood 140 , 20372052 (2022)

doi:10.1002/cbdv.200690111

Reports of stability in gastric juice are not the same as systemic bioavailability, and routes of administration in published rodent work include intraperitoneal, oral (drinking water), and topical comparisons across routes are not always controlled in primary studies (Cerovecki et al., 2010)

She notes that peptides synthesized for research purposes use a so-called TFA salt thats different and arguably more toxic than FDA-approved peptides formulated for human use